# Best Treatment Choice for Osteonecrosis of the Jaw

> **NCT04512638** · PHASE4 · UNKNOWN · sponsor: **Tim Van den Wyngaert** · enrollment: 125 (estimated)

## Conditions studied

- Medication Related Osteonecrosis of the Jaw

## Interventions

- **DRUG:** Antibiotics
- **DRUG:** Chlorhexidine mouthwash
- **PROCEDURE:** Minimally invasive surgery with LPRF
- **PROCEDURE:** Surgical resection

## Key facts

- **NCT ID:** NCT04512638
- **Lead sponsor:** Tim Van den Wyngaert
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-01
- **Primary completion:** 2025-10-01
- **Final completion:** 2026-01-01
- **Target enrollment:** 125 (ESTIMATED)
- **Last updated:** 2023-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04512638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04512638, "Best Treatment Choice for Osteonecrosis of the Jaw". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04512638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*